BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25-43. [PMID: 30171414 DOI: 10.1007/s10388-018-0642-8] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 29.3] [Reference Citation Analysis]
Number Citing Articles
1 Ishihara R, Mizusawa J, Kushima R, Matsuura N, Yano T, Kataoka T, Fukuda H, Hanaoka N, Yoshio T, Abe S, Yamamoto Y, Nagata S, Ono H, Tamaoki M, Yoshida N, Takizawa K, Muto M. Assessment of the Diagnostic Performance of Endoscopic Ultrasonography After Conventional Endoscopy for the Evaluation of Esophageal Squamous Cell Carcinoma Invasion Depth. JAMA Netw Open 2021;4:e2125317. [PMID: 34524432 DOI: 10.1001/jamanetworkopen.2021.25317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kawamoto N, Okita R, Inokawa H, Hayashi M, Furukawa M, Okada M, Okabe K. Right upper lobectomy in lung cancer with double aortic arch: A case report. Thorac Cancer 2020;11:2365-9. [PMID: 32578390 DOI: 10.1111/1759-7714.13545] [Reference Citation Analysis]
3 Zou J, Zhong X, Zhou X, Xie Q, Zhao Z, Guo X, Duan Y. The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma. Biochem Biophys Res Commun 2021;580:48-55. [PMID: 34624569 DOI: 10.1016/j.bbrc.2021.05.048] [Reference Citation Analysis]
4 Barret M, Bibault JE, Coriat R. Organ Preservation in Early Esophageal Cancer. Gastroenterology 2020;158:280. [PMID: 31628900 DOI: 10.1053/j.gastro.2019.05.079] [Reference Citation Analysis]
5 Ozawa S. Is sentinel node mapping useful for esophageal cancer surgery? Ann Gastroenterol Surg 2019;3:5-6. [PMID: 30697604 DOI: 10.1002/ags3.12231] [Reference Citation Analysis]
6 Shiozaki A, Kudou M, Fujiwara H, Konishi H, Shimizu H, Arita T, Kosuga T, Yamamoto Y, Morimura R, Ikoma H, Kuriu Y, Kubota T, Okamoto K, Otsuji E. Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: Phase I/II study (TNAC). Medicine (Baltimore) 2020;99:e23633. [PMID: 33327342 DOI: 10.1097/MD.0000000000023633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tu DH, Qu R, Wang Q, Fu X. After-hours esophagectomy may pose additional risk to patients with esophageal cancer. J Thorac Dis 2021;13:1118-29. [PMID: 33717585 DOI: 10.21037/jtd-20-3141] [Reference Citation Analysis]
8 Suzuki T, Yajima S, Okamura A, Yoshida N, Taniyama Y, Murakami K, Ohkura Y, Nakajima Y, Yagi K, Fukuda T, Ogawa R, Hoshino I, Kunisaki C, Narumiya K, Tsubosa Y, Yamada K, Shimada H; Japan Esophageal Society Promotion Research: p53 Antibody Multicenter Research Group. Prognostic impact of carcinoembryonic antigen in 1822 surgically treated esophageal squamous cell carcinoma: multi-institutional study of the Japan Esophageal Society. Dis Esophagus 2022:doac029. [PMID: 35661884 DOI: 10.1093/dote/doac029] [Reference Citation Analysis]
9 Kaida H, Kitajima K, Nakajo M, Ishibashi M, Matsunaga T, Minamimoto R, Hirata K, Nakatani K, Hung A, Hattori S, Yasuda T, Ishii K. Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan. Eur J Nucl Med Mol Imaging 2021. [PMID: 33934168 DOI: 10.1007/s00259-021-05365-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Inoue T, Ishihara R, Shibata T, Suzuki K, Kitagawa Y, Miyazaki T, Yamaji T, Nemoto K, Oyama T, Muto M, Takeuchi H, Toh Y, Matsubara H, Mano M, Kono K, Kato K, Yoshida M, Kawakubo H, Booka E, Yamatsuji T, Kato H, Ito Y, Ishikawa H, Tsushima T, Kawachi H, Oyama T, Kojima T, Kuribayashi S, Makino T, Matsuda S, Doki Y; Esophageal Cancer Practice Guidelines Preparation Committee. Endoscopic imaging modalities for diagnosing the invasion depth of superficial esophageal squamous cell carcinoma: a systematic review. Esophagus 2022. [PMID: 35397101 DOI: 10.1007/s10388-022-00918-5] [Reference Citation Analysis]
11 Kadota T, Sato D, Inaba A, Nishihara K, Takashima K, Nakajo K, Yukami H, Mishima S, Sawada K, Kotani D, Fujiwara H, Nakamura M, Hojo H, Yoda Y, Kojima T, Fujita T, Yano T. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma. Esophagus 2021. [PMID: 34420139 DOI: 10.1007/s10388-021-00873-7] [Reference Citation Analysis]
12 Yang F, Fu Y, Kumar A, Chen M, Si L, Rojanasarot S. Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China. Ann Transl Med 2021;9:1226. [PMID: 34532363 DOI: 10.21037/atm-21-1803] [Reference Citation Analysis]
13 Liu X, Guan H, Zhu Q, Tang C, Cheng F, Zeng C, Chen Y. Endoscopic Submucosal Dissection Versus Radical Surgery for T1 Superficial Esophageal Cell Carcinoma: a Subgroup Survival Analysis. J Gastrointest Canc. [DOI: 10.1007/s12029-021-00739-2] [Reference Citation Analysis]
14 Imai T, Tanaka Y, Sato Y, Mase J, Suetsugu T, Fukada M, Yasufuku I, Iwata Y, Mori R, Imai H, Kato T, Okumura N, Matsuhashi N, Takahashi T, Futamura M, Yoshida K. The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis. Indian J Surg Oncol 2021;:1-9. [PMID: 34483594 DOI: 10.1007/s13193-021-01419-0] [Reference Citation Analysis]
15 Liu Q, Zhu Z, Chen Y, Deng J, Ai D, Liu Q, Wang S, Wu S, Chen J, Zhao K. Phase 2 Study of Stereotactic Body Radiation Therapy for Patients with Oligometastatic Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2020;108:707-15. [DOI: 10.1016/j.ijrobp.2020.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hatta W, Gotoda T, Koike T, Masamune A. Management following endoscopic resection in elderly patients with early-stage upper gastrointestinal neoplasia. Dig Endosc 2020;32:861-73. [PMID: 31802529 DOI: 10.1111/den.13592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Daiko H, Marafioti T, Fujiwara T, Shirakawa Y, Nakatsura T, Kato K, Puccio I, Hikichi T, Yoshimura S, Nakagawa T, Furukawa M, Stoeber K, Nagira M, Ide N, Kojima T. Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients. Cancer Immunol Immunother 2020;69:2247-57. [PMID: 32500232 DOI: 10.1007/s00262-020-02619-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
18 Saito R, Amemiya H, Hosomura N, Kawaida H, Shoda K, Furuya S, Akaike H, Kawaguchi Y, Inoue S, Kono H, Ichikawa D. Intended preoperative trans-arterial embolization for large hepatocellular carcinoma: a retrospective cohort study. World J Surg Oncol 2022;20:90. [PMID: 35317819 DOI: 10.1186/s12957-022-02563-9] [Reference Citation Analysis]
19 Yamanashi K, Hamaji M, Tsunoda S, Nakanishi T, Omasa M, Nakajima N, Ohsumi A, Menju T, Chen-Yoshikawa TF, Date H. Survival outcomes of resection for pulmonary malignancies including non-small cell lung cancer and pulmonary metastasis after esophagectomy for esophageal carcinoma. Gen Thorac Cardiovasc Surg 2020;68:1179-86. [PMID: 32361810 DOI: 10.1007/s11748-020-01373-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Hamada K, Kanzaki H, Miyahara K, Nakagawa M, Mouri H, Mizuno M, Takahashi S, Hori S, Nasu J, Tsuzuki T, Miyaike J, Takenaka R, Yamauchi K, Kobayashi S, Toyokawa T, Inoue M, Nishimura M, Matsubara M, Tomoda J, Yamasaki Y, Tanaka T, Shirakawa Y, Kawahara Y, Fujiwara T, Okada H; Okayama Gut Study Group. Clinicopathological Characteristics of Superficial Barrett's Adenocarcinoma in a Japanese Population: A Retrospective, Multicenter Study. Intern Med 2022;61:1115-23. [DOI: 10.2169/internalmedicine.6942-20] [Reference Citation Analysis]
21 Hoshino S, Takeuchi M, Kawakubo H, Kobayashi R, Matsuda S, Irino T, Fukuda K, Nakamura R, Kitagawa Y. Neutrophil-to-lymphocyte ratio change predicts histological response to and oncological outcome of neoadjuvant chemotherapy for esophageal squamous cell carcinoma. Esophagus. [DOI: 10.1007/s10388-021-00901-6] [Reference Citation Analysis]
22 Ren JY, Zhong JD, Yuan J, Zhang JE, Li CZ, Wei WJ. Unmet supportive care needs and associated factors among Chinese discharged patients with esophageal cancer after esophagectomy: A cross-sectional study. European Journal of Oncology Nursing 2020;46:101767. [DOI: 10.1016/j.ejon.2020.101767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Marginean EC, Dhanpat J. Pathologic assessment of endoscopic resection specimens with superficial carcinoma of the esophagus: current practice and practical issues. Ann N Y Acad Sci 2020;1482:130-45. [PMID: 32875588 DOI: 10.1111/nyas.14455] [Reference Citation Analysis]
24 Booka E, Haneda R, Ishii K, Kawakami T, Tsushima T, Yasui H, Onoe T, Ogawa H, Tsubosa Y. Appropriate Candidates for Salvage Esophagectomy of Initially Unresectable Locally Advanced T4 Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2020;27:3163-3170. [PMID: 32314159 DOI: 10.1245/s10434-020-08440-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
25 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Sauri FM, Zakarneh EA, Alessa MY, Sakr AH, Chung YS, Kim HS, Kim NK. Triple synchronous primary neoplasms in the gastrointestinal tract. Chin Med J (Engl) 2021;134:1233-5. [PMID: 33538507 DOI: 10.1097/CM9.0000000000001389] [Reference Citation Analysis]
27 Yago A, Ohkura Y, Ueno M, Fujisawa K, Ogawa Y, Shimoyama H, Haruta S, Udagawa H. Importance of long-term surveillance after curative esophagectomy for esophageal squamous cell carcinoma. Dis Esophagus 2022:doab098. [PMID: 35032162 DOI: 10.1093/dote/doab098] [Reference Citation Analysis]
28 Toh Y, Inoue Y, Hayakawa M, Yamaki C, Takeuchi H, Ohira M, Matsubara H, Doki Y, Wakao F, Takayama T. Creation and provision of a question and answer resource for esophageal cancer based on medical professionals' reports of patients' and families' views and preferences. Esophagus 2021;18:872-9. [PMID: 34169363 DOI: 10.1007/s10388-021-00857-7] [Reference Citation Analysis]
29 Fan N, Wang Z, Zhou C, Bludau M, Contino G, Zhao Y, Bruns C. Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis. EClinicalMedicine 2021;42:101183. [PMID: 34805809 DOI: 10.1016/j.eclinm.2021.101183] [Reference Citation Analysis]
30 Yang L, Jin H, Xie XL, Cao YT, Liu ZH, Li N, Jin P, He YQ, Sheng JQ. Endoscopic resections for superficial esophageal squamous cell epithelial neoplasia: focus on histological discrepancies between biopsy and resected specimens. BMC Gastroenterol 2021;21:114. [PMID: 33750308 DOI: 10.1186/s12876-021-01694-9] [Reference Citation Analysis]
31 Matsubara H. Advances in the surgical treatment of esophageal cancer since 1965. Ann Gastroenterol Surg 2020;4:243-9. [PMID: 32490339 DOI: 10.1002/ags3.12332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Shin CM. [Treatment of Superficial Esophageal Cancer: An Update]. Korean J Gastroenterol 2021;78:313-9. [PMID: 34955507 DOI: 10.4166/kjg.2021.155] [Reference Citation Analysis]
33 Abe S, Oguma J, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Saito Y, Daiko H. Novel hybrid endoscopy-assisted larynx-preserving esophagectomy for cervical esophageal cancer (with video). Jpn J Clin Oncol 2021;51:1171-5. [PMID: 33855445 DOI: 10.1093/jjco/hyab045] [Reference Citation Analysis]
34 Tsunoda S, Obama K, Hisamori S, Hashimoto K, Nishigori T, Sakai Y. Simple technique of azygos arch division and retraction for minimally invasive esophagectomy. Esophagus 2021;18:169-72. [PMID: 32613326 DOI: 10.1007/s10388-020-00760-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Motoyama S, Maeda E, Iijima K, Anbai A, Sato Y, Wakita A, Nagaki Y, Fujita H, Minamiya Y, Higashi T. Differences in treatment and survival between elderly patients with thoracic esophageal cancer in metropolitan areas and other areas. Cancer Sci 2021. [PMID: 34288283 DOI: 10.1111/cas.15070] [Reference Citation Analysis]
36 Zhang W, Zhao J, Han W, Zhang H, Wang X, Li C, Chen J, Wang X, Zhao Y, Qiao X, Zhou Z, Han C, Zhu S, Shen W, Wang L, Ge X, Sun X, Zhang K, Hu M, Li L, Hao C, Li G, Xu Y, Wang Y, Lu N, Liu M, Qian S, Xiao Z, Wang P, Pang Q. Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03). Ann Transl Med 2020;8:1140. [PMID: 33240989 DOI: 10.21037/atm-20-4672] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Zhang PF, Xie D, Li Q. Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma. Future Oncol 2020;16:1189-98. [PMID: 32407173 DOI: 10.2217/fon-2019-0821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Matsuda S, Kawakubo H, Okamura A, Takahashi K, Toihata T, Takemura R, Mayanagi S, Takeuchi H, Watanabe M, Kitagawa Y. Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 34142294 DOI: 10.1245/s10434-021-10221-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Nishizawa T, Suzuki H. Long-Term Outcomes of Endoscopic Submucosal Dissection for Superficial Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2020;12:E2849. [PMID: 33023117 DOI: 10.3390/cancers12102849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Haneda R, Hiramatsu Y, Kawata S, Honke J, Soneda W, Matsumoto T, Morita Y, Kikuchi H, Kamiya K, Takeuchi H. Survival impact of perioperative changes in prognostic nutritional index levels after esophagectomy. Esophagus 2021. [PMID: 34546503 DOI: 10.1007/s10388-021-00883-5] [Reference Citation Analysis]
41 Haneda R, Booka E, Ishii K, Kikuchi H, Hiramatsu Y, Kamiya K, Ogawa H, Yasui H, Takeuchi H, Tsubosa Y. Evaluation of Definitive Chemoradiotherapy Versus Radical Esophagectomy in Clinical T1bN0M0 Esophageal Squamous Cell Carcinoma. World J Surg 2021;45:1835-44. [PMID: 33620541 DOI: 10.1007/s00268-021-06016-4] [Reference Citation Analysis]
42 Wu H, Minamide T, Yano T. Role of photodynamic therapy in the treatment of esophageal cancer. Dig Endosc 2019;31:508-16. [PMID: 30667112 DOI: 10.1111/den.13353] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
43 Kouzu K, Tsujimoto H, Ishibashi Y, Shinada H, Oikawa I, Kishi Y, Shinomiya N, Ueno H. Preoperative Fall Risk Assessment Score as a Prognostic Factor in Esophageal Cancer Patients after Esophagectomy. J Clin Med 2021;10:5966. [PMID: 34945262 DOI: 10.3390/jcm10245966] [Reference Citation Analysis]
44 Kim BR, Jang EJ, Jo J, Lee H, Jang DY, Ryu HG. The association between hospital case-volume and postoperative outcomes after esophageal cancer surgery: A population-based retrospective cohort study. Thorac Cancer 2021. [PMID: 34355527 DOI: 10.1111/1759-7714.14096] [Reference Citation Analysis]
45 Okamura A, Hayami M, Kozuki R, Takahashi K, Toihata T, Imamura Y, Mine S, Watanabe M. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma. Esophagus. 2020;17:59-66. [PMID: 31595397 DOI: 10.1007/s10388-019-00700-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
46 Li CC, Chen CY, Chou YH, Huang CJ, Ku HY, Chien CR. Chemotherapy alone versus definitive concurrent chemoradiotherapy for cT4b esophageal squamous cell carcinoma: a population-based study. BMC Gastroenterol 2021;21:153. [PMID: 33827451 DOI: 10.1186/s12876-021-01742-4] [Reference Citation Analysis]
47 Booka E, Takeuchi H, Kitagawa Y. Esophageal Cancer Practice Guidelines in Japan. In: Ando N, editor. Esophageal Squamous Cell Carcinoma. Singapore: Springer; 2020. pp. 131-47. [DOI: 10.1007/978-981-15-4190-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Fujimoto D, Taniguchi K, Takashima J, Miura F, Kobayashi H. Double tract-like gastric tube reconstruction decreases the incidences of delayed gastric emptying and bile reflux after esophagectomy: results of a pilot study of an experimental technique. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02461-4] [Reference Citation Analysis]
49 Chen Z, Huang K, Wei R, Liu C, Fang Y, Wu B, Xu Z, Ding X, Tang H. Transcervical inflatable mediastinoscopic esophagectomy versus thoracoscopic esophagectomy for local early‐ and intermediate‐stage esophageal squamous cell carcinoma: A propensity score‐matched analysis. Journal of Surgical Oncology. [DOI: 10.1002/jso.26798] [Reference Citation Analysis]
50 Zhang Q, Wu P, He X, Ding Y, Shu Y. Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China. Front Oncol 2021;11:790373. [PMID: 34926306 DOI: 10.3389/fonc.2021.790373] [Reference Citation Analysis]
51 Suzuki T, Furukawa K, Funasaka K, Ishikawa E, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Kawashima H, Miyahara R, Fujishiro M. Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection. Digestion 2021;102:563-71. [PMID: 32894837 DOI: 10.1159/000510091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Visaggi P, Barberio B, Ghisa M, Ribolsi M, Savarino V, Fassan M, Valmasoni M, Marchi S, de Bortoli N, Savarino E. Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence. Cancers (Basel) 2021;13:3162. [PMID: 34202763 DOI: 10.3390/cancers13133162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Li CC, Chen CY, Chou YH, Huang CJ, Ku HY, Chien CR. Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study. Thorac Cancer 2021;12:2065-71. [PMID: 34028200 DOI: 10.1111/1759-7714.14009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Mahawongkajit P, Boochangkool N. Comparison of Preoperative CT Colonography and Colonoscopy for Esophageal Reconstruction with Colonic Interposition. Surg Res Pract 2020;2020:6585762. [PMID: 33283041 DOI: 10.1155/2020/6585762] [Reference Citation Analysis]
55 Naito S, Yoshio T, Ishiyama A, Tsuchida T, Tokura J, Namikawa K, Tokai Y, Yoshimizu S, Horiuchi Y, Hirasawa T, Asari T, Mine S, Watanabe M, Ogura M, Chin K, Fukuzawa M, Itoi T, Fujisaki J. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig Endosc 2021. [PMID: 34599604 DOI: 10.1111/den.14154] [Reference Citation Analysis]
56 Yamada K, Chigusa Y, Nomura M, Sakanaka K, Nakamura M, Yano S, Tsunoda S, Kondoh E, Mandai M. A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy. Case Rep Obstet Gynecol 2018;2018:1280582. [PMID: 30627462 DOI: 10.1155/2018/1280582] [Reference Citation Analysis]
57 Ishihara R. Endoscopic Diagnosis and Treatment of Superficial Esophageal Squamous Cell Cancer: Present Status and Future Perspectives. Current Oncology 2022;29:534-43. [DOI: 10.3390/curroncol29020048] [Reference Citation Analysis]
58 Kato T, Oshikiri T, Goto H, Urakawa N, Hasegawa H, Kanaji S, Yamashita K, Matsuda T, Nakamura T, Suzuki S, Kakeji Y. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy. J Surg Oncol 2021;124:1022-30. [PMID: 34460103 DOI: 10.1002/jso.26611] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tu DH, Qu R, Ping W, Yang G, Ma X, Fu X, Cai Y. Double-lumen tube versus bronchial blocker in lymphadenectomy along the left recurrent laryngeal nerve for esophageal cancer: a propensity-matched analysis. Langenbecks Arch Surg 2022. [PMID: 35314875 DOI: 10.1007/s00423-022-02475-y] [Reference Citation Analysis]
60 Booka E, Kikuchi H, Hiramatsu Y, Takeuchi H. The Impact of Infectious Complications after Esophagectomy for Esophageal Cancer on Cancer Prognosis and Treatment Strategy. J Clin Med 2021;10:4614. [PMID: 34640631 DOI: 10.3390/jcm10194614] [Reference Citation Analysis]
61 Toh Y, Numasaki H, Tachimori Y, Uno T, Jingu K, Nemoto K, Matsubara H. Current status of radiotherapy for patients with thoracic esophageal cancer in Japan, based on the Comprehensive Registry of Esophageal Cancer in Japan from 2009 to 2011 by the Japan Esophageal Society. Esophagus 2020;17:25-32. [DOI: 10.1007/s10388-019-00690-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Maruyama S, Kawaguchi Y, Akaike H, Shoda K, Saito R, Shimizu H, Furuya S, Hosomura N, Amemiya H, Kawaida H, Sudo M, Inoue S, Kono H, Ichikawa D. Postoperative Complications have Minimal Impact on Long-Term Prognosis in Immunodeficient Patients with Esophageal Cancer. Ann Surg Oncol 2020;27:3064-70. [PMID: 32048090 DOI: 10.1245/s10434-020-08245-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Booka E, Haneda R, Ishii K, Tsushima T, Yasui H, Tsubosa Y. The Negative Impact of Preoperative Chemotherapy on Survival After Esophagectomy for Vulnerable Elderly Patients with Esophageal Cancer. Ann Surg Oncol 2021;28:1786-95. [PMID: 32876790 DOI: 10.1245/s10434-020-09072-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Yamamoto Y, Uedo N. Management of adverse events related to endoscopic resection of esophageal and gastric neoplasms: Report of consensus meeting. Digestive Endoscopy 2019;31:2-3. [DOI: 10.1111/den.13386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Gong EJ, Kim DH. Endoscopic Treatment for Esophageal Cancer. Korean J Helicobacter Up Gastrointest Res 2019;19:156-60. [DOI: 10.7704/kjhugr.2019.19.3.156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
66 Murakami K, Yoshida M, Uesato M, Toyozumi T, Isozaki T, Urahama R, Kano M, Matsumoto Y, Matsubara H. Does thoracoscopic esophagectomy really reduce post-operative pneumonia in all cases? Esophagus 2021;18:724-33. [PMID: 34247287 DOI: 10.1007/s10388-021-00855-9] [Reference Citation Analysis]
67 Haneda R, Kikuchi H, Nagakura Y, Notsu A, Booka E, Murakami T, Matsumoto T, Mayanagi S, Morita Y, Hiramatsu Y, Tsubosa Y, Takeuchi H. Development and Validation of the Optimal Circumferential Resection Margin in Pathological T3 Esophageal Cancer: A Multicenter, Retrospective Study. Ann Surg Oncol 2022. [PMID: 35235087 DOI: 10.1245/s10434-022-11491-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Genere JR, Priyan H, Sawas T, Hanada Y, Visrodia K, Zakko L, Iyer PG, Wong Kee Song LM, Wang KK. Safety and histologic outcomes of endoscopic submucosal dissection with a novel articulating knife for esophageal neoplasia. Gastrointestinal Endoscopy 2020;91:797-805. [DOI: 10.1016/j.gie.2019.12.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
69 Bolger JC, Donohoe CL, Lowery M, Reynolds JV. Advances in the curative management of oesophageal cancer. Br J Cancer 2021. [PMID: 34675397 DOI: 10.1038/s41416-021-01485-9] [Reference Citation Analysis]
70 Omori A, Tsunoda S, Nishigori T, Hisamori S, Hoshino N, Ikeda A, Obama K. Clinical Benefits of Routine Feeding Jejunostomy Tube Placement in Patients Undergoing Esophagectomy. J Gastrointest Surg 2022. [PMID: 35141836 DOI: 10.1007/s11605-022-05265-5] [Reference Citation Analysis]
71 Kanie Y, Okamura A, Maruyama S, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Watanabe M. Clinical Significance of Serum Squamous Cell Carcinoma Antigen for Patients with Recurrent Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021. [PMID: 33839977 DOI: 10.1245/s10434-021-09945-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Kobayashi K, Kanetaka K, Yoneda A, Kobayashi S, Maruya Y, Isagawa Y, Yoshimoto T, Migita K, Kawaguchi Y, Kuba S, Morita M, Okada S, Kosaka T, Yamaguchi S, Inoue Y, Adachi T, Hidaka M, Torashima Y, Ito S, Takatsuki M, Eguchi S. Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute Experience. J Gastrointest Cancer 2021;52:582-92. [PMID: 32524305 DOI: 10.1007/s12029-020-00431-x] [Reference Citation Analysis]
73 Nakanoko T, Morita M, Nakashima Y, Ota M, Ikebe M, Yamamoto M, Booka E, Takeuchi H, Kitagawa Y, Matsubara H, Doki Y, Toh Y. Nationwide survey of the follow-up practices for patients with esophageal carcinoma after radical treatment: historical changes and future perspectives in Japan. Esophagus 2021. [PMID: 34383154 DOI: 10.1007/s10388-021-00869-3] [Reference Citation Analysis]
74 Xu JQ, Hu JW, Chen WF, Xu MD, Zhong YS, Chen SY, Zhang YQ, Ma LL, Qin WZ, Cai MY, Yao LQ, Zhou PH, Li QL. Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy. Surg Endosc 2021;35:2229-39. [PMID: 32430528 DOI: 10.1007/s00464-020-07636-y] [Reference Citation Analysis]
75 Imamura H, Tamura S, Hattori H, Kidogami S, Mokutani Y, Kishimoto T, Hashimoto Y, Hirose H, Yoshioka S, Kuwayama M, Endo S, Sasaki Y. Coexisting primary tumors from esophageal cancer and myelodysplastic syndromes: A case report. Clin Case Rep 2021;9:e04872. [PMID: 34584722 DOI: 10.1002/ccr3.4872] [Reference Citation Analysis]
76 Tang H, Jiang D, Zhang S, Zeng Z, Tan L, Hou Y, Wang Q, Wang H, Zhu J, Shen Y, Yin J, Ge D; Zhongshan NCRT-EC working group. Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy. J Thorac Cardiovasc Surg 2020:S0022-5223(20)32634-9. [PMID: 33268125 DOI: 10.1016/j.jtcvs.2020.09.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
77 Hirahara N, Matsubara T, Fujii Y, Kaji S, Hyakudomi R, Yamamoto T, Uchida Y, Miyazaki Y, Ishitobi K, Kawabata Y, Tajima Y. Geriatric nutritional risk index as a prognostic marker of pTNM-stage I and II esophageal squamous cell carcinoma after curative resection. Oncotarget 2020;11:2834-46. [PMID: 32754301 DOI: 10.18632/oncotarget.27670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Motoyama S, Sato Y, Wakita A, Nagaki Y, Fujita H, Sasamori R, Kemuriyama K, Takashima S, Imai K, Minamiya Y. Lower local recurrence rate after robot-assisted thoracoscopic esophagectomy than conventional thoracoscopic surgery for esophageal cancer. Sci Rep 2021;11:6774. [PMID: 33762693 DOI: 10.1038/s41598-021-86420-x] [Reference Citation Analysis]
79 Fujihata S, Ogawa R, Nakaya S, Hayakawa S, Okubo T, Sagawa H, Tanaka T, Takahashi H, Matsuo Y, Takiguchi S. The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer. Esophagus 2021;18:258-66. [PMID: 32889673 DOI: 10.1007/s10388-020-00774-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Harada K, Rogers JE, Iwatsuki M, Yamashita K, Baba H, Ajani JA. Recent advances in treating oesophageal cancer. F1000Res 2020;9:F1000 Faculty Rev-1189. [PMID: 33042518 DOI: 10.12688/f1000research.22926.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Toriumi T, Yagi K, Ri M, Yajima S, Okumura Y, Aikou S, Yamashita H, Nomura S, Seto Y. Lymphatic invasion is a prognostic factor of pathological N0 esophageal squamous cell carcinoma. Dis Esophagus 2021:doab087. [PMID: 34937084 DOI: 10.1093/dote/doab087] [Reference Citation Analysis]
82 Yagi K, Toriumi T, Aikou S, Yamashita H, Seto Y. Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Ann Gastroenterol Surg 2021;5:436-45. [PMID: 34337292 DOI: 10.1002/ags3.12448] [Reference Citation Analysis]
83 Tang N, Feng Z. Endoscopic submucosal dissection combined with adjuvant chemotherapy for early-stage neuroendocrine carcinoma of the esophagus: A case report. World J Clin Cases 2022; 10(10): 3164-3169 [DOI: 10.12998/wjcc.v10.i10.3164] [Reference Citation Analysis]
84 Müller M, Posch F, Kiem D, Barth D, Horvath L, Stotz M, Schaberl-Moser R, Pichler M, Greil R, Jost PJ, Seeber A, Amann A, Schlick K, Gerger A, Riedl JM. Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis. Ther Adv Med Oncol 2021;13:17588359211039930. [PMID: 34616490 DOI: 10.1177/17588359211039930] [Reference Citation Analysis]
85 Kawamoto T, Nakamura N, Saito T, Tonari A, Wada H, Harada H, Kubota H, Nagakura H, Heianna J, Miyazawa K, Yamada K, Tago M, Fushiki M, Nozaki M, Uchida N, Araki N, Sekii S, Kosugi T, Takahashi T, Shikama N. Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan. Jpn J Clin Oncol 2021;51:950-5. [PMID: 33624768 DOI: 10.1093/jjco/hyab015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Kakeji Y, Oshikiri T, Takiguchi G, Kanaji S, Matsuda T, Nakamura T, Suzuki S. Multimodality approaches to control esophageal cancer: development of chemoradiotherapy, chemotherapy, and immunotherapy. Esophagus. 2021;18:25-32. [PMID: 32964312 DOI: 10.1007/s10388-020-00782-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
87 Ishiyama K, Oguma J, Kubo K, Kanematsu K, Fujii Y, Kurita D, Daiko H. Does Preoperative Corticosteroid Administration Improve the Short-Term Outcome of Minimally Invasive Esophagectomy for Esophageal Cancer? A Propensity Score-Matched Analysis. Ann Surg Oncol. [DOI: 10.1245/s10434-022-11821-9] [Reference Citation Analysis]
88 Saito R, Yoshimura K, Shoda K, Furuya S, Akaike H, Kawaguchi Y, Murata T, Ogata K, Iwano T, Takeda S, Ichikawa D. Diagnostic significance of plasma lipid markers and machine learning-based algorithm for gastric cancer. Oncol Lett 2021;21:405. [PMID: 33841566 DOI: 10.3892/ol.2021.12666] [Reference Citation Analysis]
89 Udagawa H. Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer. Ann Gastroenterol Surg 2020;4:324-30. [PMID: 32724875 DOI: 10.1002/ags3.12338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
90 Yamauchi K, Iwamuro M, Nakagawa M, Takenaka R, Matsueda K, Inaba T, Yoshioka M, Toyokawa T, Tanaka S, Kanzaki H, Kawano S, Kawahara Y, Shirakawa Y, Okada H; Okayama Gut Study Group. Long-term outcomes of endoscopic versus surgical resection for MM-SM1 esophageal squamous cell carcinoma using propensity score analysis. Esophagus 2021;18:72-80. [PMID: 32876825 DOI: 10.1007/s10388-020-00775-0] [Reference Citation Analysis]
91 Xu J, Li Y, Fan Q, Shu Y, Yang L, Cui T, Gu K, Tao M, Wang X, Cui C, Xu N, Xiao J, Gao Q, Liu Y, Zhang T, Bai Y, Li W, Zhang Y, Dai G, Ma D, Zhang J, Bai C, Huang Y, Liao W, Wu L, Chen X, Yang Y, Wang J, Ji S, Zhou H, Wang Y, Ma Z, Wang Y, Peng B, Sun J, Mancao C. Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2). Nat Commun 2022;13. [DOI: 10.1038/s41467-022-28408-3] [Reference Citation Analysis]
92 Zhang Y, Zhang J, Pan G, Guan T, Zhang C, Hao A, Li Y, Ren H. Effects of EFNA1 on cell phenotype and prognosis of esophageal carcinoma. World J Surg Oncol 2021;19:242. [PMID: 34399788 DOI: 10.1186/s12957-021-02362-8] [Reference Citation Analysis]
93 Kobayashi S, Taniguchi K, Tanaka F, Maeda S, Hirayama T, Tokunaga T, Takeshita H, Miura S, Kuroki T. Cricopharyngeal myotomy for cricopharyngeus muscle dysfunction after esophagectomy. Surg Case Rep 2020;6:205. [PMID: 32785797 DOI: 10.1186/s40792-020-00961-3] [Reference Citation Analysis]
94 Urabe M, Ueno M, Udagawa H. Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: Experiences related to esophageal cancer surgery. Head Neck 2020;42:3098-9. [PMID: 32761686 DOI: 10.1002/hed.26392] [Reference Citation Analysis]
95 Okabe H, Tsunoda S, Sunagawa H, Saji M, Hirai K, Nakau M, Tanaka E, Obama K. A long-term follow-up study of minimally invasive Ivor Lewis esophagectomy with linear stapled anastomosis. Surg Endosc 2021. [PMID: 33837477 DOI: 10.1007/s00464-021-08482-2] [Reference Citation Analysis]
96 Shimizu D, Koike M, Kanda M, Sonohara F, Hattori N, Hayashi M, Tanaka C, Yamada S, Kodera Y. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus. Surg Today 2021;51:153-8. [PMID: 32638131 DOI: 10.1007/s00595-020-02072-w] [Reference Citation Analysis]
97 Shinozaki H, Matsuoka T, Ozawa S. Pharmacological treatment to reduce pulmonary morbidity after esophagectomy. Ann Gastroenterol Surg 2021;5:614-22. [PMID: 34585046 DOI: 10.1002/ags3.12469] [Reference Citation Analysis]
98 Toriyama K, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Onishi S, Mizuno N, Kuwahara T, Okuno N, Matsumoto S, Sasaki E, Abe T, Yatabe Y, Hara K, Matsuo K, Tamaki T, Niwa Y. Clinical relevance of fluorodeoxyglucose positron emission tomography/computed tomography and magnifying endoscopy with narrow band imaging in decision-making regarding the treatment strategy for esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(46): 6767-6780 [PMID: 31857778 DOI: 10.3748/wjg.v25.i46.6767] [Reference Citation Analysis]
99 Yamamoto S, Kato K. Immuno-oncology for esophageal cancer. Future Oncol 2020;16:2673-81. [PMID: 32777942 DOI: 10.2217/fon-2020-0545] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
100 Gondo T, Sonoo T, Hashimoto H, Nakamura K. Chemoradiation therapy for oesophageal cancer with airway stenosis under mechanical ventilation with light sedation using dexmedetomidine alone. BMJ Case Rep 2020;13:e234507. [PMID: 32816929 DOI: 10.1136/bcr-2020-234507] [Reference Citation Analysis]
101 Cellini F, Manfrida S, Casà C, Romano A, Arcelli A, Zamagni A, De Luca V, Colloca GF, D'Aviero A, Fuccio L, Lancellotta V, Tagliaferri L, Boldrini L, Mattiucci GC, Gambacorta MA, Morganti AG, Valentini V. Modern Management of Esophageal Cancer: Radio-Oncology in Neoadjuvancy, Adjuvancy and Palliation. Cancers (Basel) 2022;14:431. [PMID: 35053594 DOI: 10.3390/cancers14020431] [Reference Citation Analysis]
102 Shin JH, Kunisawa S, Fushimi K, Imanaka Y. Effects of preoperative oral management by dentists on postoperative outcomes following esophagectomy: Multilevel propensity score matching and weighting analyses using the Japanese inpatient database. Medicine (Baltimore) 2019;98:e15376. [PMID: 31027127 DOI: 10.1097/MD.0000000000015376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
103 Sun Y, Wang J, Ma Y, Li J, Sun X, Zhao X, Shi X, Hu Y, Qu F, Zhang X. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p. J Exp Clin Cancer Res 2021;40:306. [PMID: 34587992 DOI: 10.1186/s13046-021-02084-5] [Reference Citation Analysis]
104 Xie C, Jing Z, Luo H, Jiang W, Ma L, Hu W, Zheng A, Li D, Ding L, Zhang H, Xie C, Lian X, Du D, Chen M, Bian X, Tan B, Xia B, Xie R, Liu Q, Wang L, Wu S. Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial. Br J Cancer 2020;123:1616-24. [PMID: 32958820 DOI: 10.1038/s41416-020-01054-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
105 Kanda M, Koike M, Shimizu D, Tanaka C, Hattori N, Hayashi M, Yamada S, Omae K, Kodera Y. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Ann Surg Oncol 2020;27:3195-205. [PMID: 32246314 DOI: 10.1245/s10434-020-08433-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
106 Suzuki T, Okamura A, Watanabe M, Mine S, Imamura Y, Asari T, Osumi H, Nakayama I, Ichimura T, Ogura M, Ooki A, Takahari D, Yamaguchi K, Chin K. Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2020;27:1510-7. [DOI: 10.1245/s10434-019-08124-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
107 Tsunoda S, Obama K, Hisamori S, Nishigori T, Okamura R, Maekawa H, Sakai Y. Lower Incidence of Postoperative Pulmonary Complications Following Robot-Assisted Minimally Invasive Esophagectomy for Esophageal Cancer: Propensity Score-Matched Comparison to Conventional Minimally Invasive Esophagectomy. Ann Surg Oncol 2021;28:639-47. [PMID: 32892268 DOI: 10.1245/s10434-020-09081-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
108 Harada K, Zhao M, Baba H, Ajani JA. Endoscopic resection for esophageal or gastroesophageal junction adenocarcinoma. Dig Med Res 2019;2:7. [PMID: 31179442 DOI: 10.21037/dmr.2019.04.01] [Reference Citation Analysis]
109 Takahashi M, Takahashi K, Muguruma K, Ohira M, Nagayama K. Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer. Int J Clin Oncol 2021. [PMID: 34686932 DOI: 10.1007/s10147-021-02057-w] [Reference Citation Analysis]
110 Okamura A, Matsuda S, Mayanagi S, Kanamori J, Imamura Y, Irino T, Kawakubo H, Mine S, Takeuchi H, Kitagawa Y, Watanabe M. Clinical Significance of Pretherapeutic Serum Squamous Cell Carcinoma Antigen Level in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2021;28:1209-16. [PMID: 32524457 DOI: 10.1245/s10434-020-08716-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
111 Hamada K, Itoh T, Kawaura K, Kuno H, Kamai J, Kobayasi R, Azukisawa S, Kitakata H, Ishisaka T, Igarashi Y, Kodera K, Okuno T, Morita T, Himeno T, Yano H, Higashikawa T, Iritani O, Iwai K, Morimoto S, Matoba M, Okuro M. A Case of Refractory Esophageal Ulcer Caused by Radiotherapy for Hepatocellular Carcinoma. World J Oncol 2021;12:67-72. [PMID: 34046101 DOI: 10.14740/wjon1370] [Reference Citation Analysis]
112 Booka E, Tsubosa Y, Yokota T, Mayanagi S, Ishii K, Urakami K, Ohshima K, Ohnami S, Nagashima T, Yamaguchi K. Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGA. Esophagus 2021;18:743-52. [PMID: 33826001 DOI: 10.1007/s10388-021-00835-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Fujihata S, Ogawa R, Ito S, Hayakawa S, Nakaya S, Okubo T, Sagawa H, Tanaka T, Takahashi H, Matsuo Y, Takiguchi S. Diagnosis of recurrent laryngeal nerve paralysis following esophagectomy by evaluating movement of the vocal cords and arytenoid cartilages using ultrasonography. Esophagus 2021;18:704-9. [PMID: 33950417 DOI: 10.1007/s10388-021-00830-4] [Reference Citation Analysis]
114 Tamaoki M, Yokoyama A, Horimatsu T, Hirohashi K, Amanuma Y, Higuchi H, Mitani Y, Yoshioka M, Ohashi S, Muto M. Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy. Esophagus 2021;18:817-24. [PMID: 34106353 DOI: 10.1007/s10388-021-00853-x] [Reference Citation Analysis]
115 Davakis S, Syllaios A, Mpaili E, Liakakos T, Charalabopoulos A. Laparoscopic-assisted Esophageal Bypass for T4b Esophageal Tumor as a Bridge to Definitive Therapy. In Vivo 2020;34:2163-8. [PMID: 32606199 DOI: 10.21873/invivo.12024] [Reference Citation Analysis]
116 Lampis A, Ratti M, Ghidini M, Mirchev MB, Okuducu AF, Valeri N, Hahne JC. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review). Int J Mol Med 2021;47:97. [PMID: 33846775 DOI: 10.3892/ijmm.2021.4930] [Reference Citation Analysis]
117 Wang CY, Chen BH, Lee CH, Le PH, Tsou YK, Lin CH. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy. Cancers (Basel) 2022;14:424. [PMID: 35053586 DOI: 10.3390/cancers14020424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Urabe M, Haruta S, Ohkura Y, Yago A, Koga S, Tanaka T, Ueno M, Udagawa H. Diaphragmatic herniation following total gastrectomy: review of the long-term experience of a tertiary institution. Langenbecks Arch Surg 2019;404:993-8. [PMID: 31745625 DOI: 10.1007/s00423-019-01842-6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
119 Toh Y, Yamamoto H, Miyata H, Gotoh M, Watanabe M, Matsubara H, Kakeji Y, Seto Y. Significance of the board-certified surgeon systems and clinical practice guideline adherence to surgical treatment of esophageal cancer in Japan: a questionnaire survey of departments registered in the National Clinical Database. Esophagus 2019;16:362-70. [PMID: 30980202 DOI: 10.1007/s10388-019-00672-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
120 Chang JW, Jung DH, Huh CW, Park JC, Shin SK, Lee SK, Lee YC. Long-Term Outcomes and Prognostic Factors of Superficial Esophageal Cancer in Patients Aged ≥ 65 Years. Front Med 2022;8:722141. [DOI: 10.3389/fmed.2021.722141] [Reference Citation Analysis]
121 Oyama T. Endoscopic diagnosis and treatment of superficial Barrett's esophageal adenocarcinoma: Japanese perspective. Dig Endosc 2021. [PMID: 34622523 DOI: 10.1111/den.14147] [Reference Citation Analysis]
122 Tanaka T, Ueno M, Iizuka T, Hoteya S, Haruta S, Udagawa H. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma. Dis Esophagus 2019;32:doz023. [PMID: 30980070 DOI: 10.1093/dote/doz023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
123 Zhang L, Ke L, Wu X, Tian H, Deng H, Xu L, Li E, Long L, Formanowicz D. TRIP13 Induces Nedaplatin Resistance in Esophageal Squamous Cell Carcinoma by Enhancing Repair of DNA Damage and Inhibiting Apoptosis. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/7295458] [Reference Citation Analysis]
124 Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JA. Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg 2021;273:751-7. [PMID: 31188215 DOI: 10.1097/SLA.0000000000003383] [Reference Citation Analysis]
125 Chen Z, Dou L, Liu Y, Zhang Y, He S, Xue L, Wang G. Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions. Front Oncol 2021;11:786015. [PMID: 34900740 DOI: 10.3389/fonc.2021.786015] [Reference Citation Analysis]
126 Kim GH, Jung HY. Endoscopic Resection for the Treatment of Superficial Esophageal Neoplasms. Korean J Thorac Cardiovasc Surg 2020;53:172-7. [PMID: 32793448 DOI: 10.5090/kjtcs.2020.53.4.172] [Reference Citation Analysis]
127 Borgstein ABJ, Brunner S, Hayami M, Moons J, Fuchs H, Eshuis WJ, Gisbertz SS, Bruns CJ, Nafteux P, Nilsson M, Schröder W, van Berge Henegouwen MI. Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study. Ann Surg Oncol 2021;28:4805-13. [PMID: 33830357 DOI: 10.1245/s10434-021-09886-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
128 Hirose T, Yamamoto S, Kato K. Emerging data on nivolumab for esophageal squamous cell carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:845-54. [PMID: 34251958 DOI: 10.1080/17474124.2021.1948836] [Reference Citation Analysis]
129 Zhuang X, Chen Z, Wang J, Chen J, Wu X, Wang Y, Chen C, Deng G, Qian K, Bai Y. Clinicopathological features and outcomes of esophageal lesions containing a basal layer type squamous cell carcinoma component. Cancer Manag Res 2019;11:8507-16. [PMID: 31572005 DOI: 10.2147/CMAR.S212380] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: Towards targeted therapies. Cell Oncol (Dordr) 2020;43:195-209. [PMID: 31848929 DOI: 10.1007/s13402-019-00488-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
131 Cao Y, Qin S, Luo S, Li Z, Cheng Y, Fan Y, Sun Y, Yin X, Yuan X, Li W, Liu T, Hsu CH, Lin X, Kim SB, Kojima T, Zhang J, Lee SH, Bai Y, Muro K, Doi T, Bai C, Gu K, Pan HM, Bai L, Yang JW, Cui Y, Lu W, Chen J. Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia. ESMO Open 2021;7:100341. [PMID: 34973513 DOI: 10.1016/j.esmoop.2021.100341] [Reference Citation Analysis]
132 Motoyama S, Maeda E, Yano M, Yasuda T, Ohira M, Kajiyama Y, Higashi T, Doki Y, Matsubara H. Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching. Esophagus 2020;17:141-8. [PMID: 31939000 DOI: 10.1007/s10388-019-00712-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Tang H, Tan L, Wang H, Shen Y, Yin J. Nodal Downstaging of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy: Survival Analysis if ypN0 Is Achieved. J Gastrointest Surg 2020;24:1469-76. [DOI: 10.1007/s11605-019-04317-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
134 Fan M, Dai L, Yan W, Yang Y, Lin Y, Chen K. Efficacy of programmed cell death protein 1 inhibitor in resection transformation treatment of esophageal cancer. Thorac Cancer 2021;12:2182-8. [PMID: 34137505 DOI: 10.1111/1759-7714.14054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
135 Mahawongkajit P, Techagumpuch A, Limpavitayaporn P, Kanlerd A, Sriussadaporn E, Juntong J, Tongyoo A, Mingmalairak C. Comparison of Introducer Percutaneous Endoscopic Gastrostomy with Open Gastrostomy in Advanced Esophageal Cancer Patients. Dysphagia 2020;35:117-20. [PMID: 31025103 DOI: 10.1007/s00455-019-10017-w] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
136 Yu M, Tan Y, Liu D. Strategies to prevent stricture after esophageal endoscopic submucosal dissection. Ann Transl Med 2019;7:271. [PMID: 31355238 DOI: 10.21037/atm.2019.05.45] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
137 Kawashima K, Abe S, Koga M, Nonaka S, Suzuki H, Yoshinaga S, Oda I, Hikichi T, Ohira H, Saito Y. Optimal selection of endoscopic resection in patients with esophageal squamous cell carcinoma: endoscopic mucosal resection versus endoscopic submucosal dissection according to lesion size. Diseases of the Esophagus 2021;34:doaa096. [DOI: 10.1093/dote/doaa096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
138 Matsuda S, Kawakubo H, Irino T, Kitagawa Y. Role sharing between minimally invasive oesophagectomy and organ preservation approach for surgically resectable advanced oesophageal cancer. Jpn J Clin Oncol 2021:hyab192. [PMID: 34891170 DOI: 10.1093/jjco/hyab192] [Reference Citation Analysis]
139 Azuma Y, Dohi O, Naito Y, Yasuda T, Yoshida T, Ishida T, Kitae H, Matsumura S, Doi T, Hirose R, Inoue K, Yoshida N, Kamada K, Uchiyama K, Takagi T, Ishikawa T, Konishi H, Nishimura A, Kishimoto M, Itoh Y. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma. Esophagus 2021. [PMID: 34773554 DOI: 10.1007/s10388-021-00894-2] [Reference Citation Analysis]
140 Takahashi M, Kato K, Okada M, Chin K, Kadowaki S, Hamamoto Y, Doki Y, Kubota Y, Kawakami H, Ogata T, Hara H, Muto M, Nakashima Y, Ishihara R, Tsuda M, Motoyama S, Kodani M, Kitagawa Y. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus 2021;18:90-9. [PMID: 33170461 DOI: 10.1007/s10388-020-00794-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, Yen CC, Kubota Y, Kim SB, Hsu CH, Holtved E, Xynos I, Kodani M, Kitagawa Y. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2019;20:1506-17. [PMID: 31582355 DOI: 10.1016/S1470-2045(19)30626-6] [Cited by in Crossref: 205] [Cited by in F6Publishing: 127] [Article Influence: 68.3] [Reference Citation Analysis]
142 Fukuda S, Okajima K, Okada K, Fukuda K, Wakasa T, Tsujimoto T, Gakuhara A, Tomihara H, Ohta K, Kitani K, Hashimoto K, Ishikawa H, Hida JI, Yukawa M, Ohta Y, Inoue M. Postoperative solitary liver metastasis from esophageal squamous cell carcinoma achieving a clinical complete response to chemotherapy with cisplatin and 5-fluorouracil followed by stereotactic body radiotherapy: A case report. Mol Clin Oncol 2021;15:130. [PMID: 34055345 DOI: 10.3892/mco.2021.2292] [Reference Citation Analysis]
143 Yajima S, Sugawara K, Iwai M, Tanaka M, Seto Y, Todo T. Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma. Mol Ther Oncolytics 2021;23:402-11. [PMID: 34853811 DOI: 10.1016/j.omto.2021.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Taketa T, Uchiyama Y, Kodama N, Koyama T, Domen K. Rehabilitation Management for a Patient with Bilateral Pneumothorax after Surgery for Esophageal Cancer. PRM 2022;7:n/a. [DOI: 10.2490/prm.20220017] [Reference Citation Analysis]
145 Yura M, Koyanagi K, Hara A, Hayashi K, Tajima Y, Kaneko Y, Fujisaki H, Hirata A, Takano K, Hongo K, Yo K, Yoneyama K, Tamai Y, Dehari R, Nakagawa M. Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report. World J Clin Cases 2021; 9(12): 2801-2810 [PMID: 33969062 DOI: 10.12998/wjcc.v9.i12.2801] [Reference Citation Analysis]
146 Hirose W, Taniyama Y, Fujishima F, Sato C, Unno M, Kamei T. Salvage esophagectomy for local recurrent esophageal cancer after definitive chemoradiotherapy followed by photodynamic therapy: A case report. Int J Surg Case Rep 2021;80:105617. [PMID: 33592421 DOI: 10.1016/j.ijscr.2021.02.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Akutsu T, Fujita T, Kajiyama D, Ozaki A, Sato K, Fujiwara H, Kojima T, Daiko H. Operative outcomes and long-term survival of patients undergoing colon interposition after esophagectomy for cancer. Thorac Cancer 2022. [PMID: 35088520 DOI: 10.1111/1759-7714.14332] [Reference Citation Analysis]
148 Suzuki T, Okamura A, Watanabe M, Chin K. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma? Ann Surg Oncol 2020;27:1518-9. [PMID: 32108921 DOI: 10.1245/s10434-020-08282-3] [Reference Citation Analysis]
149 Yan Z, Xu X, Lu J, You Y, Xu J, Xu T. Development and validation of a nomogram for prediction of cervical lymph node metastasis in middle and lower thoracic esophageal squamous cell carcinoma. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02243-8] [Reference Citation Analysis]
150 Imai T, Tanaka Y, Ojio H, Sato Y, Suetsugu T, Fukada M, Yasufuku I, Iwata Y, Imai H, Okumura N, Matsuhashi N, Takahashi T, Noguchi K, Miyazaki T, Yoshida K. Successful treatment of cervical and upper thoracic esophageal adenocarcinoma using induction chemotherapy followed by surgery: a case report. Int Cancer Conf J 2021;10:334-40. [PMID: 34567948 DOI: 10.1007/s13691-021-00505-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Dermine S, Lévi-Strauss T, Abou Ali E, Belle A, Leblanc S, Bibault JE, Barré A, Palmieri LJ, Brezault C, Dhooge M, Terris B, Dohan A, Soyer P, Berger A, Rahmi G, Coriat R, Chaussade S, Barret M. Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node Involvement. Cancers (Basel) 2020;12:E3598. [PMID: 33276430 DOI: 10.3390/cancers12123598] [Reference Citation Analysis]
152 Hara T, Makino T, Yamasaki M, Tanaka K, Yamashita K, Nogi Y, Saito T, Takahashi T, Kurokawa Y, Tatsumi M, Nakajima K, Morii E, Eguchi H, Doki Y. Peritumoral Lymphatic Vessels Associated with Resistance to Neoadjuvant Chemotherapy and Unfavorable Survival in Esophageal Cancer. Ann Surg Oncol 2020;27:3762-9. [PMID: 32328984 DOI: 10.1245/s10434-020-08474-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Hayashi M, Abe M, Fujita T, Matsushita H. Assessing the Prognostic Value of Extranodal Extension in Esophageal Cancer from the Pathological Staging Perspective. J Invest Surg 2021;:1-9. [PMID: 34096439 DOI: 10.1080/08941939.2021.1912221] [Reference Citation Analysis]
154 Narusaka T, Ohara T, Noma K, Nishiwaki N, Katsura Y, Kato T, Sato H, Tomono Y, Kikuchi S, Tazawa H, Shirakawa Y, Matsukawa A, Fujiwara T. Nanog is a promising chemoresistant stemness marker and therapeutic target by iron chelators for esophageal cancer. Int J Cancer 2021;149:347-57. [PMID: 33662150 DOI: 10.1002/ijc.33544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Maruyama S, Okamura A, Kanie Y, Sakamoto K, Fujiwara D, Kanamori J, Imamura Y, Kumagai K, Watanabe M. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg 2022. [PMID: 35420308 DOI: 10.1007/s00423-022-02508-6] [Reference Citation Analysis]